Amedeo Smart

Free Medical Literature Service



Ischemic Heart Disease

  Free Subscription


1 Am Heart J
3 Am J Cardiol
3 Am J Emerg Med
2 Angiology
2 Arterioscler Thromb Vasc Biol
35 Atherosclerosis
3 Can J Cardiol
2 Cardiovasc Res
7 Catheter Cardiovasc Interv
1 Circ Cardiovasc Interv
2 Circ Cardiovasc Qual Outcomes
1 Circ J
6 Circulation
1 Clin Cardiol
2 Int J Cardiol
2 Int J Cardiol Hypertens
1 J Am Coll Cardiol
1 J Cardiovasc Pharmacol
7 J Electrocardiol
1 J Mol Cell Cardiol
1 Mayo Clin Proc
1 N Engl J Med
3 PLoS One

    Am Heart J

  1. FERNANDEZ-ALVIRA JM, Fernandez-Jimenez R, de Miguel M, Santos-Beneit G, et al
    The challenge of sustainability: long-term results from the Fifty-Fifty peer group-based intervention in cardiovascular risk factors.
    Am Heart J. 2021 Jun 17. pii: S0002-8703(21)00162.
    >> Share

    Am J Cardiol

  2. NOAMAN S, Dinh D, Reid CM, Brennan AL, et al
    Comparison of Outcomes of Coronary Artery Disease Treated by Percutaneous Coronary Intervention in 3 Different Age Groups (<45, 46-65, and >65 Years).
    Am J Cardiol. 2021 Jun 16. pii: S0002-9149(21)00410.
    >> Share

  3. SEKI H, Kaneko H, Morita H, Itoh H, et al
    Relation of Serum Uric Acid and Cardiovascular Events in Adults Aged 20-49 Years.
    Am J Cardiol. 2021 Jun 14. pii: S0002-9149(21)00426.
    >> Share

  4. ABOU R, Goedemans L, Montero-Cabezas JM, Prihadi EA, et al
    Prognostic Value of Multilayer Left Ventricular Global Longitudinal Strain in Patients with ST-segment Elevation Myocardial Infarction with Mildly Reduced Left Ventricular Ejection Fractions.
    Am J Cardiol. 2021 Jun 20. pii: S0002-9149(21)00411.
    >> Share

    Am J Emerg Med

  5. GOLDEN DL, Freedman ZS, Hennessy CL, Wright R, et al
    Disimpaction induced NSTEMI.
    Am J Emerg Med. 2021;43:288.
    >> Share

  6. WU TT, Yang DL, Li H, Guo YS, et al
    Development and validation of a nomogram to predict in-hospital cardiac arrest among patients admitted with acute coronary syndrome.
    Am J Emerg Med. 2021;49:240-248.
    >> Share

  7. MENG F, Guo F, Abulimiti B, Zhao K, et al
    Body mass index and all-cause mortality in patients with cardiogenic shock: A systematic review and meta-analysis.
    Am J Emerg Med. 2021;43:97-102.
    >> Share


  8. SANLIALP SC, Sanlialp M
    Should We Use Fasting Glucose and the Glycated Hemoglobin (HbA1c) in Evaluation of Coronary Artery Disease?
    Angiology. 2021 Jun 18:33197211026418. doi: 10.1177/00033197211026418.
    >> Share

  9. LIN S, Chen S, Yan H, Dou K, et al
    Clinical Outcomes in Chronic Total Occlusion Revascularization Versus No Chronic Total Occlusion Revascularization: Variability by Target Vessel.
    Angiology. 2021;72:565-574.
    >> Share

    Arterioscler Thromb Vasc Biol

  10. CORNELISSEN A, Guo L, Fernandez R, Kelly MC, et al
    Endothelial Recovery in Bare Metal Stents and Drug-Eluting Stents on a Single-Cell Level.
    Arterioscler Thromb Vasc Biol. 2021 Jun 24:ATVBAHA121316472.
    >> Share

  11. KINDBLOM JM, Bygdell M, Hjelmgren O, Martikainen J, et al
    Pubertal Body Mass Index Change Is Associated With Adult Coronary Atherosclerosis and Acute Coronary Events in Men.
    Arterioscler Thromb Vasc Biol. 2021 Jun 17:ATVBAHA121316265.
    >> Share


  12. SHI F, Sun L, Kaptoge S
    Association of beta-2-microglobulin and cardiovascular events and mortality: A systematic review and meta-analysis.
    Atherosclerosis. 2021;320:70-78.
    >> Share

  13. DE WINTER RW, Schumacher SP, Stuijfzand WJ, van Diemen PA, et al
    Evolution of coronary artery calcium and absolute myocardial perfusion after percutaneous revascularization: A 3-year serial hybrid [(15)O]H2O PET/CT imaging study.
    Atherosclerosis. 2021;318:22-31.
    >> Share

  14. OSEI AD, Mirbolouk M, Berman D, Budoff MJ, et al
    Prognostic value of coronary artery calcium score, area, and density among individuals on statin therapy vs. non-users: The coronary artery calcium consortium.
    Atherosclerosis. 2021;316:79-83.
    >> Share

  15. VARSHNEY AS, Coskun AU, Siasos G, Maynard CC, et al
    Spatial relationships among hemodynamic, anatomic, and biochemical plaque characteristics in patients with coronary artery disease.
    Atherosclerosis. 2021;320:98-104.
    >> Share

  16. KLINGENBERG R, Aghlmandi S, Gencer B, Nanchen D, et al
    Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events.
    Atherosclerosis. 2021;320:31-37.
    >> Share

  17. NANNA MG, Peterson ED, Chiswell K, Overton RA, et al
    The incremental value of angiographic features for predicting recurrent cardiovascular events: Insights from the Duke Databank for Cardiovascular Disease.
    Atherosclerosis. 2021;321:1-7.
    >> Share

  18. ARCHER JM, Raggi P, Amin SB, Zhang C, et al
    Season and clinical factors influence epicardial adipose tissue attenuation measurement on computed tomography and may hamper its utilization as a risk marker.
    Atherosclerosis. 2021;321:8-13.
    >> Share

  19. GUGLIELMO M, Lin A, Dey D, Baggiano A, et al
    Epicardial fat and coronary artery disease: Role of cardiac imaging.
    Atherosclerosis. 2021;321:30-38.
    >> Share

  20. KEDHI E, Verdoia M, Suryapranata H, Damen S, et al
    Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial.
    Atherosclerosis. 2021;321:39-44.
    >> Share

  21. TUFARO V, Safi H, Torii R, Koo BK, et al
    Wall shear stress estimated by 3D-QCA can predict cardiovascular events in lesions with borderline negative fractional flow reserve.
    Atherosclerosis. 2021;322:24-30.
    >> Share

  22. MONTONE RA, Meucci MC, De Vita A, Lanza GA, et al
    Coronary provocative tests in the catheterization laboratory: Pathophysiological bases, methodological considerations and clinical implications.
    Atherosclerosis. 2021;318:14-21.
    >> Share

  23. MAJEED K, Bellinge JW, Butcher SC, Alcock R, et al
    Coronary (18)F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndrome.
    Atherosclerosis. 2021;319:142-148.
    >> Share

  24. ZDANYTE M, Wrazidlo RW, Kaltenbach S, Groga-Bada P, et al
    Predicting 1-, 3- and 5-year outcomes in patients with coronary artery disease: A comparison of available risk assessment scores.
    Atherosclerosis. 2020;318:1-7.
    >> Share

  25. VERGALLO R, Jang IK, Crea F
    New prediction tools and treatment for ACS patients with plaque erosion.
    Atherosclerosis. 2021;318:45-51.
    >> Share

  26. COLLET C, Conte E, Mushtaq S, Brouwers S, et al
    Reviewing imaging modalities for the assessment of plaque erosion.
    Atherosclerosis. 2021;318:52-59.
    >> Share

  27. BITTNER DO, Goeller M, Dey D, Zopf Y, et al
    High levels of eicosapentaenoic acid are associated with lower pericoronary adipose tissue attenuation as measured by coronary CTA.
    Atherosclerosis. 2021;316:73-78.
    >> Share

    Role of mechanical stress and neutrophils in the pathogenesis of plaque erosion.
    Atherosclerosis. 2021;318:60-69.
    >> Share

  29. TAMARAPPOO BK, Lin A, Commandeur F, McElhinney PA, et al
    Machine learning integration of circulating and imaging biomarkers for explainable patient-specific prediction of cardiac events: A prospective study.
    Atherosclerosis. 2021;318:76-82.
    >> Share

  30. SUGANE H, Kataoka Y, Otsuka F, Nakaoku Y, et al
    Cardiac outcomes in patients with acute coronary syndrome attributable to calcified nodule.
    Atherosclerosis. 2021;318:70-75.
    >> Share

  31. PEREZ DE ISLA L, Alonso R, Gomez de Diego JJ, Muniz-Grijalvo O, et al
    Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study.
    Atherosclerosis. 2020 Nov 18. pii: S0021-9150(20)31521.
    >> Share

  32. HEFFRON SP, Ruuth MK, Xia Y, Hernandez G, et al
    Low-density lipoprotein aggregation predicts adverse cardiovascular events in peripheral artery disease.
    Atherosclerosis. 2021;316:53-57.
    >> Share

  33. GAO Y, Lou Y, Liu Y, Wu S, et al
    The relationship between residual cholesterol risk and plaque characteristics in patients with acute coronary syndrome: Insights from an optical coherence tomography study.
    Atherosclerosis. 2021;317:10-15.
    >> Share

  34. AL RIFAI M, Kanaya AM, Kandula NR, Cainzos-Achirica M, et al
    Distribution of calcium volume, density, number, and type of coronary vessel with calcified plaque in South Asians in the US and other race/ethnic groups: The MASALA and MESA studies.
    Atherosclerosis. 2021;317:16-21.
    >> Share

  35. ZAFEIROPOULOS S, Farmakis I, Kartas A, Arvanitaki A, et al
    Reinforcing adherence to lipid-lowering therapy after an acute coronary syndrome: A pragmatic randomized controlled trial.
    Atherosclerosis. 2021;323:37-43.
    >> Share

  36. WON KB, Heo R, Park HB, Lee BK, et al
    Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors.
    Atherosclerosis. 2021;324:46-51.
    >> Share

  37. COENEN DM, Heinzmann ACA, Karel MFA, Cosemans JMEM, et al
    The multifaceted contribution of platelets in the emergence and aftermath of acute cardiovascular events.
    Atherosclerosis. 2021;319:132-141.
    >> Share

  38. KITAHARA S, Kataoka Y, Miura H, Nishii T, et al
    The feasibility and limitation of coronary computed tomographic angiography imaging to identify coronary lipid-rich atheroma in vivo: Findings from near-infrared spectroscopy analysis.
    Atherosclerosis. 2021;322:1-7.
    >> Share

  39. BJERRE M, Hilden J, Winkel P, Jensen GB, et al
    Serum osteoprotegerin as a long-term predictor for patients with stable coronary artery disease and its association with diabetes and statin treatment: A CLARICOR trial 10-year follow-up substudy.
    Atherosclerosis. 2020;301:8-14.
    >> Share

  40. GULIZIA MM, Maggioni AP, Abrignani MG, Bilato C, et al
    Prevalence Of familial hypercholeSTerolaemia (FH) in Italian Patients with coronary artERy disease: The POSTER study.
    Atherosclerosis. 2020;308:32-38.
    >> Share

  41. FUKUMOTO K, Takemoto Y, Yoshikawa J, Norioka N, et al
    Predictors of endothelial function improvement in patients with mild hypertriglyceridemia without evidence of coronary artery disease treated with purified eicosapentaenoic acid.
    Atherosclerosis. 2020;309:27-32.
    >> Share

  42. SHROFF GR, Sanchez OA, Miedema MD, Kramer H, et al
    Coronary artery calcium progresses rapidly and discriminates incident cardiovascular events in chronic kidney disease regardless of diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Atherosclerosis. 2020;310:75-82.
    >> Share

  43. BELL S, Gibson JT, Harshfield EL, Markus HS, et al
    Is periodontitis a risk factor for ischaemic stroke, coronary artery disease and subclinical atherosclerosis? A Mendelian randomization study.
    Atherosclerosis. 2020;313:111-117.
    >> Share

  44. WANG L, Zhou W, Guo M, Hua Y, et al
    The gut microbiota is associated with clinical response to statin treatment in patients with coronary artery disease.
    Atherosclerosis. 2021;325:16-23.
    >> Share

  45. VILAHUR G, Sutelman P, Mendieta G, Ben-Aicha S, et al
    Triglyceride-induced cardiac lipotoxicity is mitigated by Silybum marianum.
    Atherosclerosis. 2021;324:91-101.
    >> Share

  46. CHO H, Kang SJ, Min HS, Lee JG, et al
    Intravascular ultrasound-based deep learning for plaque characterization in coronary artery disease.
    Atherosclerosis. 2021;324:69-75.
    >> Share


  47. VALGIMIGLI M, Gragnano F, Branca M, Franzone A, et al
    P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials.
    BMJ. 2021;373:n1332.
    >> Share

    Can J Cardiol

  48. ALYAMANI M, Campbell S, Navarese E, Welsh RC, et al
    Safety and Efficacy of Intracoronary Thrombolysis as Adjunctive Therapy to Primary PCI in STEMI: A Systematic Review and Meta-analysis.
    Can J Cardiol. 2021;37:339-346.
    >> Share

  49. SEMSAR-KAZEROONI K, Dima D, Valiquette J, Berube-Dufour J, et al
    Early Mobilization in People With Acute Cardiovascular Disease.
    Can J Cardiol. 2021;37:232-240.
    >> Share

  50. NGUYEN CH, Marzolini S, Oh P, Thomas SG, et al
    A Retrospective Comparison of Fitness and Exercise Progression in Patients With Coronary and Peripheral Artery Disease in Cardiac Rehabilitation.
    Can J Cardiol. 2021;37:260-268.
    >> Share

    Cardiovasc Res

    Sphingosine-1-phosphate receptor-1 (S1PR1) signalling: the homeostatic pathway of the heart.
    Cardiovasc Res. 2021;117:357-359.
    >> Share

  52. LECOUR S
    Remote ischaemic conditioning modulates platelet reactivity: the need to optimize the therapy is more important than ever before.
    Cardiovasc Res. 2021;117:346-347.
    >> Share

    Catheter Cardiovasc Interv

  53. GRINES CL, Yen A
    Between a rock and a hard place: Orbital atherectomy for under-expanded stents.
    Catheter Cardiovasc Interv. 2021;97:8-9.
    >> Share

  54. SMITH T, Henry TD
    Spontaneous coronary artery dissection with cardiogenic shock: How frequent is it? How should we treat it?
    Catheter Cardiovasc Interv. 2021;97:78-79.
    >> Share

  55. BALTER S, Moses JW
    Intravascular brachytherapy is a good clinical option for refractory in-stent restenosis.
    Catheter Cardiovasc Interv. 2021;97:39-40.
    >> Share

  56. RODRIGUEZ-PAZ E, Heuser R
    "Back to the future: Beta radiation to treat recurrent in-stent restenosis".
    Catheter Cardiovasc Interv. 2021;97:47.
    >> Share

  57. KRAJCER Z, Costello B
    Clinical impact of calcified nodules in patients with heavily calcified lesions requiring rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;97:20-21.
    >> Share

  58. KIM Y, Shapero K, Ahn SS, Goldsweig AM, et al
    Outcomes of mechanical circulatory support for acute myocardial infarction complicated by cardiogenic shock.
    Catheter Cardiovasc Interv. 2021 Jun 22. doi: 10.1002/ccd.29834.
    >> Share

  59. KERN MJ
    Is stealing still a crime? Comment on left internal mammary artery side branch intervention in the management of coronary steal syndrome following coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021;97:105-107.
    >> Share

    Circ Cardiovasc Interv

  60. KUNO T, Ikemura N, Kohsaka S
    Letter by Kuno et al Regarding Article, "Heart Team/Guidelines Discordance Is Associated With Increased Mortality: Data From a National Survey of Revascularization in Patients With Complex Coronary Artery Disease".
    Circ Cardiovasc Interv. 2021 Jun 21:CIRCINTERVENTIONS121010649.
    >> Share

    Circ Cardiovasc Qual Outcomes

  61. LEE HL, Kim JT, Lee JS, Park MS, et al
    Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Mild-to-Moderate Acute Ischemic Stroke According to the Risk of Recurrent Stroke: An Analysis of 15 000 Patients From a Nationwide, Multi
    Circ Cardiovasc Qual Outcomes. 2020;13:e006474.
    >> Share

  62. GALAVIZ KI, Barnes GD
    Implementation Science Opportunities in Cardiovascular Medicine.
    Circ Cardiovasc Qual Outcomes. 2021 Jun 21:CIRCOUTCOMES121008109.
    >> Share

    Circ J

  63. DEL VAL D, Bastante T, Gordillo CH, Aguilar R, et al
    "Milking-Like" Effect as Predictor of Left Ventricular Free Wall Rupture Following Acute Myocardial Infarction.
    Circ J. 2021 Jun 16. doi: 10.1253/circj.CJ-21-0079.
    >> Share


  64. Correction to: A Randomized Trial of a 1-Hour Troponin T Protocol in Suspected Acute Coronary Syndromes: The Rapid Assessment of Possible Acute Coronary Syndrome in the Emergency Department With High-Sensitivity Troponin T Study (RAPID-TnT).
    Circulation. 2021;143:e1118.
    >> Share

  65. DROBNI ZD, Mayrhofer T, Hoffmann U, Neilan TG, et al
    Response to Sarayani et al Regarding Article, "Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque".
    Circulation. 2021;143:e1033-e1034.
    >> Share

  66. SARAYANI A, Jugl S, Winterstein AG
    Letter by Sarayani et al Regarding Article, "Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque".
    Circulation. 2021;143:e1031-e1032.
    >> Share

  67. REILLY MP, Bornfeldt KE
    Integrative Multiomics Approaches for Discovery of New Drug Targets for Cardiovascular Disease.
    Circulation. 2021;143:2471-2474.
    >> Share

  68. YEGHIAZARIANS Y, Jneid H, Tietjens JR, Redline S, et al
    Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Jun 21:CIR0000000000000988. doi: 10.1161/CIR.0000000000000988.
    >> Share

  69. Correction to: Temporal Release of High-Sensitivity Cardiac Troponin T and I and Copeptin After Brief Induced Coronary Artery Balloon Occlusion in Humans.
    Circulation. 2021;143:e1116.
    >> Share

    Clin Cardiol

  70. CHEN Y, Chen Y, Wen F, He Z, et al
    Does continuous positive airway pressure therapy benefit patients with coronary artery disease and obstructive sleep apnea? A systematic review and meta-analysis.
    Clin Cardiol. 2021 Jun 19. doi: 10.1002/clc.23669.
    >> Share

    Int J Cardiol

  71. VERDOIA M, Brancati MF, Solda PL
    Commentary to: "Prognosis of spontaneous myocardial infarction and various definitions of periprocedural myocardial infarction in patients who underwent percutaneous coronary intervention".
    Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)00983.
    >> Share

  72. HOLZKNECHT M, Tiller C, Reindl M, Lechner I, et al
    C-reactive protein velocity predicts microvascular pathology after acute ST-elevation myocardial infarction.
    Int J Cardiol. 2021 Jun 18. pii: S0167-5273(21)00982.
    >> Share

    Int J Cardiol Hypertens

  73. VOLPE R
    Critical questions in cardiovascular risk: What nutrition labels should be used on food?
    Int J Cardiol Hypertens. 2021;9:100095.
    >> Share

  74. ELIJOVICH F, Laffer CL
    Why is salt-sensitivity of blood pressure, a known cardiovascular risk factor, not treated?
    Int J Cardiol Hypertens. 2021;9:100096.
    >> Share

    J Am Coll Cardiol

    Marfan Syndrome: Expanding the Cardiovascular Phenotype?
    J Am Coll Cardiol. 2021;77:3013-3015.
    >> Share

    J Cardiovasc Pharmacol

  76. ZHANG J, Tang Y, Zhang J, Wang J, et al
    CircRNA ACAP2 is overexpressed in myocardial infarction and promotes the maturation of miR-532 to induce the apoptosis of cardiomyocyte.
    J Cardiovasc Pharmacol. 2021 Jun 15. pii: 00005344-900000000-98198.
    >> Share

    J Electrocardiol

  77. TSIANAKAS N, Bordignon S, Bologna F, Tohoku S, et al
    Holter ECG diagnosis of nicotine-spray induced ventricular fibrillation. An unusual case of Prinzmetal variant angina.
    J Electrocardiol. 2020;63:17-20.
    >> Share

  78. CRAVENS MG, Ali SF, Gibbs MA, Littmann L, et al
    Real-time validation of the Sgarbossa and modified Sgarbossa criteria in intermittent left bundle branch block.
    J Electrocardiol. 2020;63:24-27.
    >> Share

  79. BIGLER MR, Zimmermann P, Papadis A, Seiler C, et al
    Accuracy of intracoronary ECG parameters for myocardial ischemia detection.
    J Electrocardiol. 2021;64:50-57.
    >> Share

  80. KITAZAWA H, Sato A, Okabe M, Aizawa Y, et al
    J waves induced during coronary angiography in patients with vasospastic angina and its implication.
    J Electrocardiol. 2021;64:99-101.
    >> Share

  81. LIU J, Birnbaum Y
    ST segment elevation following coronary artery bypass surgery.
    J Electrocardiol. 2019;57:128-131.
    >> Share

  82. ANDREOU AY, Atieh ZAH, Pham ATA
    A patient with simultaneous anterior and inferior ST-segment elevation after percutaneous coronary intervention.
    J Electrocardiol. 2019;57:24-26.
    >> Share

  83. OZBEK SC, Sokmen E
    Usefulness of Tp-Te interval and Tp-Te/QT ratio in the prediction of ventricular arrhythmias and mortality in acute STEMI patients undergoing fibrinolytic therapy.
    J Electrocardiol. 2019;56:100-105.
    >> Share

    J Mol Cell Cardiol

  84. KUBOTA A, Suto A, Suga K, Iwata A, et al
    Inhibition of Interleukin-21 prolongs the survival through the promotion of wound healing after myocardial infarction.
    J Mol Cell Cardiol. 2021;159:48-61.
    >> Share


  85. SATO T, Terada R, Ikeda T
    Effect of Restrictive or Liberal Blood Transfusion on Major Cardiovascular Events in Patients With Acute Myocardial Infarction and Anemia.
    JAMA. 2021;325:2505-2506.
    >> Share

  86. DUCROCQ G, Simon T, Steg PG
    Effect of Restrictive or Liberal Blood Transfusion on Major Cardiovascular Events in Patients With Acute Myocardial Infarction and Anemia-Reply.
    JAMA. 2021;325:2506-2507.
    >> Share

    Mayo Clin Proc

  87. CORBAN MT, Toya T, Ahmad A, Lerman LO, et al
    Atrial Fibrillation and Endothelial Dysfunction: A Potential Link?
    Mayo Clin Proc. 2021;96:1609-1621.
    >> Share

    N Engl J Med

  88. LAU ES, Scirica B, Schaefer IM, Miller AL, et al
    Hypertensive Heartbreak.
    N Engl J Med. 2021;384:2145-2152.
    >> Share

    PLoS One

  89. FARDMAN A, Zahger D, Orvin K, Oren D, et al
    Acute myocardial infarction in the Covid-19 era: Incidence, clinical characteristics and in-hospital outcomes-A multicenter registry.
    PLoS One. 2021;16:e0253524.
    >> Share

  90. BEOM JH, Kim JH, Seo J, Lee JH, et al
    Targeted temperature management at 33 degrees C or 36 induces equivalent myocardial protection by inhibiting HMGB1 release in myocardial ischemia/reperfusion injury.
    PLoS One. 2021;16:e0246066.
    >> Share

  91. CROUSER ED, Julian MW, Bicer S, Ghai V, et al
    Circulating exosomal microRNA expression patterns distinguish cardiac sarcoidosis from myocardial ischemia.
    PLoS One. 2021;16:e0246083.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016